Induction of cytochrome P450 3A4 by docetaxel in peripheral mononuclear cells and its expression in lung cancer

被引:25
作者
Fujitaka, K
Oguri, T
Isobe, T
Fujiwara, Y
Kohno, N
机构
[1] Hiroshima Univ, Fac Med, Dept Internal Med 2, Minami Ku, Hiroshima 7348551, Japan
[2] Natl Inst Hlth Sci, Pharmaceut & Med Devices Evaluat Ctr, Evaluat Div 2, Tokyo 158, Japan
关键词
CYP3A4; docetaxel; induction; RT-PCR;
D O I
10.1007/s002800100291
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several recent studies have demonstrated that the cytochrome p450 (CYP) family plays an important role in the metabolism of taxanes. However. the role of CYP gene expression in tumors and peripheral mononuclear cells (PMN) is unknown. We therefore investigated the levels of CYP3A4 and CYP2C gene expression using reverse transcription polymerase chain reaction (RT-PCR) in PMN from 16 previously untreated lung cancer patients to determine whether the expression of the two genes is induced by docetaxel (TXT). Neither the CYP3A4 nor the CYP2C gene was induced after administration of carboplatin (CBDCA) alone. Expression of the CYP3A4 gene was induced by the administration of TXT alone or TXT and CBDCA. but expression of the CYP2C gene was unaffected. We also measured the expression of both genes using RT-PCR in 20 autopsy samples (ten non-small-cell lung cancers and their corresponding normal lung tissues) obtained from patients who had not received any chemotherapy during life. The level of CYP2C gene expression in samples of lung cancer was significantly higher than in normal lung tissue. but the level of CYP3A4 gene expression was not. These results suggest that the CYP3A4 gene is induced by TXT, and that it plays an important role in intracellular TXT metabolism.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 35 条
  • [21] Inhibition and induction of cytochrome P450 and the clinical implications
    Lin, JH
    Lu, AYH
    [J]. CLINICAL PHARMACOKINETICS, 1998, 35 (05) : 361 - 390
  • [22] MARRE F, 1996, CANCER RES, V56, P129
  • [23] Mechetner E, 1998, CLIN CANCER RES, V4, P389
  • [24] Monsarrat B, 1998, DRUG METAB DISPOS, V26, P229
  • [25] ENHANCED INTERACTION BETWEEN TUBULIN AND MICROTUBULE-ASSOCIATED PROTEIN-2 VIA INHIBITION OF MAP KINASE AND CDC2 KINASE BY PACLITAXEL
    NISHIO, K
    ARIOKA, H
    ISHIDA, T
    FUKUMOTO, H
    KUROKAWA, H
    SATA, M
    OHATA, M
    SAIJO, N
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (05) : 688 - 693
  • [26] Induction of γ-glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patients
    Oguri, T
    Fujiwara, Y
    Miyazaki, M
    Takahashi, T
    Kurata, T
    Yokozaki, M
    Ohashi, N
    Isobe, T
    Katoh, O
    Yamakido, M
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (04) : 455 - 460
  • [27] Expression of γ-glutamylcysteine synthetase (γ-GCS) and multidrug resistance associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs
    Oguri, T
    Fujiwara, Y
    Isobe, T
    Katoh, O
    Watanabe, H
    Yamakido, M
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (07) : 1089 - 1096
  • [28] CHARACTERIZATION OF A TAXOL-RESISTANT HUMAN SMALL-CELL LUNG-CANCER CELL-LINE
    OHTA, S
    NISHIO, K
    KUBOTA, N
    OHMORI, T
    FUNAYAMA, Y
    OHIRA, T
    NAKAJIMA, H
    ADACHI, M
    SAIJO, N
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (03): : 290 - 297
  • [29] Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
    Pronk, LC
    Schellens, JHM
    Planting, AST
    vandenBent, MJ
    Hilkens, PHE
    vanderBurg, MEL
    deBoerDennert, M
    Ma, J
    Blanc, C
    Harteveld, M
    Bruno, R
    Stoter, G
    Verweij, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1071 - 1079
  • [30] RAHMAN A, 1994, CANCER RES, V54, P5543